Z

Zymeworks Inc
F:0OX

Watchlist Manager
Zymeworks Inc
F:0OX
Watchlist
Price: 26.85 EUR 3.87% Market Closed
Market Cap: 1.2B EUR

Relative Value

0OX price has not been updated for more than 2 years. This may indicate that the stock has been delisted.

There is not enough data to reliably calculate the relative value of 0OX.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

0OX Relative Value
Base Case
Not Available
Z
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
17.6
Median 5Y
18.8
Industry
8.2
Forward
11.5
vs History
vs Industry
Median 3Y
-11.2
Median 5Y
-7.5
Industry
24.2
Forward
-22
vs History
vs Industry
Median 3Y
-11.3
Median 5Y
-9.6
Industry
23
vs History
vs Industry
Median 3Y
-10.9
Median 5Y
-9.2
Industry
25.5
vs History
vs Industry
Median 3Y
2.9
Median 5Y
3.1
Industry
3.3
vs History
vs Industry
Median 3Y
12.7
Median 5Y
13.9
Industry
8.6
Forward
8.5
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
10.5
vs History
vs Industry
Median 3Y
-7.5
Median 5Y
-5.5
Industry
6.1
Forward
-9.3
vs History
vs Industry
Median 3Y
-7
Median 5Y
-5.4
Industry
6.6
Forward
-13.7
vs History
vs Industry
Median 3Y
-8.1
Median 5Y
-7.1
Industry
8.8
vs History
vs Industry
Median 3Y
-7.8
Median 5Y
-6.8
Industry
6.8
vs History
vs Industry
Median 3Y
4.8
Median 5Y
5.4
Industry
5.7

Multiples Across Competitors

0OX Competitors Multiples
Zymeworks Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
Zymeworks Inc
F:0OX
1.2B EUR 18.9 -12.1 -8.3 -7.7
IL
Can Fite Biopharma Ltd
TASE:CANF
17.7m ILS 6.4 -0.4 0.1 0.1
FR
Pharnext SCA
OTC:PNEXF
6T USD 34 170 980.7 -162 409.6 -197 217.1 -194 966.6
US
Abbvie Inc
NYSE:ABBV
383.1B USD 6.4 163.1 15.9 22.5
US
Amgen Inc
NASDAQ:AMGN
177.6B USD 4.9 25.3 18.3 18.3
US
Gilead Sciences Inc
NASDAQ:GILD
150.6B USD 5.2 18.6 12.5 12.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
111.5B USD 9.5 30.3 22.2 23.2
US
Epizyme Inc
F:EPE
94.1B EUR 2 061.7 -526.1 -572.9 -557.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.1B USD 5.5 17.1 16.2 18.4
AU
CSL Ltd
ASX:CSL
85.1B AUD 3.7 19 12.8 16
NL
argenx SE
XBRU:ARGX
42.6B EUR 13.7 32.3 55.5 57
P/S Multiple
Revenue Growth P/S to Growth
CA
Z
Zymeworks Inc
F:0OX
Average P/S: 3 106 647
18.9
26%
0.7
IL
C
Can Fite Biopharma Ltd
TASE:CANF
6.4
140%
0
FR
Pharnext SCA
OTC:PNEXF
34 170 980.7
N/A N/A
US
Abbvie Inc
NYSE:ABBV
6.4
9%
0.7
US
Amgen Inc
NASDAQ:AMGN
4.9
5%
1
US
Gilead Sciences Inc
NASDAQ:GILD
5.2
4%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
9.5
10%
1
US
E
Epizyme Inc
F:EPE
2 061.7
N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
5.5
6%
0.9
AU
CSL Ltd
ASX:CSL
3.7
5%
0.7
NL
argenx SE
XBRU:ARGX
13.7
49%
0.3
P/E Multiple
Earnings Growth PEG
CA
Z
Zymeworks Inc
F:0OX
Average P/E: 43.7
Negative Multiple: -12.1
N/A N/A
IL
C
Can Fite Biopharma Ltd
TASE:CANF
Negative Multiple: -0.4 N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -162 409.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
163.1
89%
1.8
US
Amgen Inc
NASDAQ:AMGN
25.3
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
18.6
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
30.3
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -526.1 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.1
10%
1.7
AU
CSL Ltd
ASX:CSL
19
11%
1.7
NL
argenx SE
XBRU:ARGX
32.3
40%
0.8
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CA
Z
Zymeworks Inc
F:0OX
Average EV/EBITDA: 19.2
Negative Multiple: -8.3
N/A N/A
IL
C
Can Fite Biopharma Ltd
TASE:CANF
0.1
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -197 217.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.9
14%
1.1
US
Amgen Inc
NASDAQ:AMGN
18.3
11%
1.7
US
Gilead Sciences Inc
NASDAQ:GILD
12.5
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
22.2
16%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -572.9 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.2
11%
1.5
AU
CSL Ltd
ASX:CSL
12.8
8%
1.6
NL
argenx SE
XBRU:ARGX
55.5
810%
0.1
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CA
Z
Zymeworks Inc
F:0OX
Average EV/EBIT: 21
Negative Multiple: -7.7
N/A N/A
IL
C
Can Fite Biopharma Ltd
TASE:CANF
0.1
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 966.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
22.5
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
18.3
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.5
12%
1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.2
16%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -557.6 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.4
13%
1.4
AU
CSL Ltd
ASX:CSL
16
11%
1.5
NL
argenx SE
XBRU:ARGX
57
N/A N/A